Suppr超能文献

胆道感染与菌血症:临床表现、结构异常、致病微生物及临床结局

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

作者信息

Melzer M, Toner R, Lacey S, Bettany E, Rait G

机构信息

King George Hospital, Barking, Havering and Redbridge Trust, Barley Lane, Goodmayes, Essex IG3 8YB, UK.

出版信息

Postgrad Med J. 2007 Dec;83(986):773-6. doi: 10.1136/pgmj.2007.064683.

Abstract

BACKGROUND

Biliary tract infection is a common cause of bacteraemia and is associated with high morbidity and mortality. Few papers describe blood culture isolates, underlying structural abnormalities and clinical outcomes in patients with bacteraemia.

AIMS

To determine the proportion of bacteraemias caused by biliary tract infection and to describe patient demographics, underlying structural abnormalities and clinical outcomes in patients with bacteraemia.

DESIGN

Prospective cohort study.

METHODS

Biliary tract infection that caused bacteraemia was defined as a compatible clinical syndrome and a blood culture isolate consistent with ascending cholangitis. Patients aged 16 years and over were included in the study. From June 2003 to May 2005, demographic and clinical data were collected prospectively on all adult patients with bacteraemia. Radiological and endoscopic retrograde cholangiopancreatography findings were collected retrospectively.

RESULTS

In 49 patients, the biliary tract was the site of infection for 39/592 (6.6%) community-acquired and 19/466 (4.1%) hospital-acquired episodes of bacteraemia. Three patients had mixed bacteraemias, and four had recurrent bacteraemia. The proportion of patients presenting with a structural abnormality was 34/49 (69%), and, of these structural abnormalities, 18/34 (53%) were pre-existing or newly diagnosed malignancies. Gram-negative organisms caused 55/58 (95%) episodes of bacteraemia. The most common Gram-negative organisms were Escherichia coli (34/55; 62%) and Klebsiella pneumoniae (14/55; 26%). Of the E coli isolates, 6/34 (18%) were extended spectrum beta-lactamase producers or multiply drug resistant. Thirty-day mortality was 7/49 (14%). There was no difference in time taken to administer an effective antibiotic to survivors and non-survivors (0.86 vs 1.05 days, respectively, p = 0.92). Of the seven who died, four died from septic shock within 48 h of admission caused by "susceptible" Gram-negative organisms. Two others died from disseminated malignancy.

CONCLUSIONS

The proportion of bacteraemias caused by biliary tract infection was 5.5%. The most common infecting organisms were E coli and K pneumoniae. There was a strong association with choledocholithiasis and malignancies, both pre-existing and newly diagnosed. Death was uncommon but when it occurred was often caused by septic shock within 48 h of presentation.

摘要

背景

胆道感染是菌血症的常见病因,与高发病率和死亡率相关。很少有论文描述菌血症患者的血培养分离株、潜在结构异常和临床结局。

目的

确定由胆道感染引起的菌血症比例,并描述菌血症患者的人口统计学特征、潜在结构异常和临床结局。

设计

前瞻性队列研究。

方法

将导致菌血症的胆道感染定义为一种相符的临床综合征以及与上行性胆管炎一致的血培养分离株。纳入研究的患者年龄在16岁及以上。2003年6月至2005年5月,前瞻性收集了所有成年菌血症患者的人口统计学和临床数据。回顾性收集了放射学和内镜逆行胰胆管造影检查结果。

结果

在49例患者中,胆道是39/592例(6.6%)社区获得性菌血症发作和19/466例(4.1%)医院获得性菌血症发作的感染部位。3例患者有混合菌血症,4例有复发性菌血症。出现结构异常的患者比例为34/49(69%),在这些结构异常中,18/34(53%)为既往存在或新诊断的恶性肿瘤。革兰阴性菌导致55/58例(95%)菌血症发作。最常见的革兰阴性菌是大肠埃希菌(34/55;62%)和肺炎克雷伯菌(14/55;26%)。在大肠埃希菌分离株中,6/34(18%)是超广谱β-内酰胺酶产生菌或多重耐药菌。30天死亡率为7/49(14%)。幸存者和非幸存者给予有效抗生素的时间无差异(分别为0.86天和1.05天,p = 0.92)。在死亡的7例患者中,4例在入院后48小时内死于由“敏感”革兰阴性菌引起的感染性休克。另外2例死于播散性恶性肿瘤。

结论

由胆道感染引起的菌血症比例为5.5%。最常见的感染菌是大肠埃希菌和肺炎克雷伯菌。与胆总管结石及既往存在和新诊断的恶性肿瘤有很强的关联。死亡并不常见,但一旦发生,往往是在发病后48小时内死于感染性休克。

相似文献

2
Strategy to reduce bacteraemia based on cohort data from a London teaching hospital.
Postgrad Med J. 2018 Apr;94(1110):212-215. doi: 10.1136/postgradmedj-2017-135454. Epub 2018 Feb 20.
6
Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
Postgrad Med J. 2011 Nov;87(1033):757-62. doi: 10.1136/pgmj.2010.116616. Epub 2011 Jul 28.
7
Clinical impact of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with biliary tract infection.
Dig Dis Sci. 2013 Mar;58(3):841-9. doi: 10.1007/s10620-012-2398-7. Epub 2012 Sep 14.
8
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.
Clin Microbiol Infect. 2013 Feb;19(2):E72-9. doi: 10.1111/1469-0691.12091. Epub 2012 Dec 12.

引用本文的文献

4
Value of using blood routine indicators combined with artificial intelligence in sepsis patients.
Am J Transl Res. 2025 Apr 15;17(4):2678-2689. doi: 10.62347/MMNQ1017. eCollection 2025.
5
7
Navigating antibiotic therapy in acute cholangitis: Best practices and new insights.
J Hepatobiliary Pancreat Sci. 2025 Jan;32(1):44-57. doi: 10.1002/jhbp.12087. Epub 2024 Nov 13.
8
Significant Microbial Pathogenesis Perspective of Biliary Diseases.
Infect Disord Drug Targets. 2025;25(4):e18715265302000. doi: 10.2174/0118715265302000240913092037.
9
Draft genomes of the bile duct microbiome strains and isolated from bilioenteric drainages with biofilm-forming abilities.
Microbiol Resour Announc. 2024 Dec 12;13(12):e0020224. doi: 10.1128/mra.00202-24. Epub 2024 Oct 29.

本文引用的文献

1
Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis.
Am J Gastroenterol. 2007 Mar;102(3):563-9. doi: 10.1111/j.1572-0241.2007.01095.x.
2
What if it's acute cholangitis?
Drug Ther Bull. 2005 Aug;43(8):62-4. doi: 10.1136/dtb.2005.43862.
3
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.
J Antimicrob Chemother. 2005 Jul;56(1):52-9. doi: 10.1093/jac/dki166. Epub 2005 May 25.
4
Management of cholangitis.
J Hepatobiliary Pancreat Surg. 2003;10(6):406-14. doi: 10.1007/s00534-002-0710-1.
5
Diagnosis and management of cholecystitis and cholangitis.
Gastroenterol Clin North Am. 2003 Dec;32(4):1145-68. doi: 10.1016/s0889-8553(03)00090-6.
9
Endoscopic retrograde cholangiopancreatography in elderly patients.
Age Ageing. 1998 Nov;27(6):683-8. doi: 10.1093/ageing/27.6.683.
10
Urinary tract infections in the elderly.
Br J Urol. 1998 Dec;82 Suppl 1:79-84. doi: 10.1046/j.1464-410x.1998.0820s1079.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验